Joseph T. Brozinick
Eli Lilly and Company
Lilly Corporate Center
Indianapolis
IN 46285
USA
Name/email consistency: high
- "Actin"g on GLUT4: membrane & cytoskeletal components of insulin action. Brozinick, J.T., Berkemeier, B.A., Elmendorf, J.S. Curr. Diabetes. Rev (2007)
- Disruption of cortical actin in skeletal muscle demonstrates an essential role of the cytoskeleton in glucose transporter 4 translocation in insulin-sensitive tissues. Brozinick, J.T., Hawkins, E.D., Strawbridge, A.B., Elmendorf, J.S. J. Biol. Chem. (2004)
- Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance. Brozinick, J.T., Roberts, B.R., Dohm, G.L. Diabetes (2003)
- 1-[N, O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosyl]-4- phenylpiperazine (KN-62), an inhibitor of calcium-dependent camodulin protein kinase II, inhibits both insulin- and hypoxia-stimulated glucose transport in skeletal muscle. Brozinick, J.T., Reynolds, T.H., Dean, D., Cartee, G., Cushman, S.W. Biochem. J. (1999)
- Insulin, but not contraction, activates Akt/PKB in isolated rat skeletal muscle. Brozinick, J.T., Birnbaum, M.J. J. Biol. Chem. (1998)
The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.








